These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 10892758)

  • 41. Effects of acarbose on cardiovascular and diabetes outcomes in patients with coronary heart disease and impaired glucose tolerance (ACE): a randomised, double-blind, placebo-controlled trial.
    Holman RR; Coleman RL; Chan JCN; Chiasson JL; Feng H; Ge J; Gerstein HC; Gray R; Huo Y; Lang Z; McMurray JJ; Rydén L; Schröder S; Sun Y; Theodorakis MJ; Tendera M; Tucker L; Tuomilehto J; Wei Y; Yang W; Wang D; Hu D; Pan C;
    Lancet Diabetes Endocrinol; 2017 Nov; 5(11):877-886. PubMed ID: 28917545
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Early symptom-limited exercise test for risk stratification in post menopausal women with unstable coronary artery disease. FRISC study group. Fragmin during Instability in Coronary Artery Disease.
    Säfström K; Swahn E
    Eur Heart J; 2000 Feb; 21(3):230-8. PubMed ID: 10639305
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Radial versus femoral access and bivalirudin versus unfractionated heparin in invasively managed patients with acute coronary syndrome (MATRIX): final 1-year results of a multicentre, randomised controlled trial.
    Valgimigli M; Frigoli E; Leonardi S; Vranckx P; Rothenbühler M; Tebaldi M; Varbella F; Calabrò P; Garducci S; Rubartelli P; Briguori C; Andó G; Ferrario M; Limbruno U; Garbo R; Sganzerla P; Russo F; Nazzaro M; Lupi A; Cortese B; Ausiello A; Ierna S; Esposito G; Ferrante G; Santarelli A; Sardella G; de Cesare N; Tosi P; van 't Hof A; Omerovic E; Brugaletta S; Windecker S; Heg D; Jüni P;
    Lancet; 2018 Sep; 392(10150):835-848. PubMed ID: 30153988
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Long-term results of RITA-1 trial: clinical and cost comparisons of coronary angioplasty and coronary-artery bypass grafting. Randomised Intervention Treatment of Angina.
    Henderson RA; Pocock SJ; Sharp SJ; Nanchahal K; Sculpher MJ; Buxton MJ; Hampton JR
    Lancet; 1998 Oct; 352(9138):1419-25. PubMed ID: 9807988
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Ranolazine in patients with incomplete revascularisation after percutaneous coronary intervention (RIVER-PCI): a multicentre, randomised, double-blind, placebo-controlled trial.
    Weisz G; Généreux P; Iñiguez A; Zurakowski A; Shechter M; Alexander KP; Dressler O; Osmukhina A; James S; Ohman EM; Ben-Yehuda O; Farzaneh-Far R; Stone GW;
    Lancet; 2016 Jan; 387(10014):136-45. PubMed ID: 26474810
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Long-term outcome after an early invasive versus selective invasive treatment strategy in patients with non-ST-elevation acute coronary syndrome and elevated cardiac troponin T (the ICTUS trial): a follow-up study.
    Hirsch A; Windhausen F; Tijssen JG; Verheugt FW; Cornel JH; de Winter RJ;
    Lancet; 2007 Mar; 369(9564):827-835. PubMed ID: 17350451
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Relationship between interleukin 6 and mortality in patients with unstable coronary artery disease: effects of an early invasive or noninvasive strategy.
    Lindmark E; Diderholm E; Wallentin L; Siegbahn A
    JAMA; 2001 Nov; 286(17):2107-13. PubMed ID: 11694151
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Long-term outcome of a routine versus selective invasive strategy in patients with non-ST-segment elevation acute coronary syndrome a meta-analysis of individual patient data.
    Fox KA; Clayton TC; Damman P; Pocock SJ; de Winter RJ; Tijssen JG; Lagerqvist B; Wallentin L;
    J Am Coll Cardiol; 2010 Jun; 55(22):2435-45. PubMed ID: 20359842
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Acute and prolonged treatment with low-molecular-weight heparin therapy in patients with unstable coronary artery disease.
    Husted S; Kher A
    Ann Med; 2000 Dec; 32 Suppl 1():53-9. PubMed ID: 11209983
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Diabetes mellitus: the major risk factor in unstable coronary artery disease even after consideration of the extent of coronary artery disease and benefits of revascularization.
    Norhammar A; Malmberg K; Diderholm E; Lagerqvist B; Lindahl B; Rydén L; Wallentin L
    J Am Coll Cardiol; 2004 Feb; 43(4):585-91. PubMed ID: 14975468
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Invasive treatment in unstable coronary artery disease promotes health-related quality of life: results from the FRISC II trial.
    Janzon M; Levin LA; Swahn E
    Am Heart J; 2004 Jul; 148(1):114-21. PubMed ID: 15215800
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study.
    Mehta SR; Yusuf S; Peters RJ; Bertrand ME; Lewis BS; Natarajan MK; Malmberg K; Rupprecht H; Zhao F; Chrolavicius S; Copland I; Fox KA;
    Lancet; 2001 Aug; 358(9281):527-33. PubMed ID: 11520521
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Current management of unstable angina: lessons from the TACTICS-TIMI 18 trial.
    Manoharan G; Adgey AA
    Am J Cardiovasc Drugs; 2002; 2(4):237-43. PubMed ID: 14727969
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Prognosis and treatment in patients admitted with acute myocardial infarction on weekends and weekdays from 1997 to 2009.
    Hansen KW; Hvelplund A; Abildstrøm SZ; Prescott E; Madsen M; Madsen JK; Jensen JS; Sørensen R; Galatius S
    Int J Cardiol; 2013 Sep; 168(2):1167-73. PubMed ID: 23199552
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Early invasive versus selectively invasive management for acute coronary syndromes.
    de Winter RJ; Windhausen F; Cornel JH; Dunselman PH; Janus CL; Bendermacher PE; Michels HR; Sanders GT; Tijssen JG; Verheugt FW;
    N Engl J Med; 2005 Sep; 353(11):1095-104. PubMed ID: 16162880
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Low-molecular weight heparin and acute coronary syndrome: theoretical background and its use in clinical practice].
    Ottani F; Ferrini D; Di Pasquale G; Galvani M
    Ital Heart J Suppl; 2001 Sep; 2(9):958-71. PubMed ID: 11675833
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Coronary angioplasty versus medical therapy for angina: the second Randomised Intervention Treatment of Angina (RITA-2) trial. RITA-2 trial participants.
    Lancet; 1997 Aug; 350(9076):461-8. PubMed ID: 9274581
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Comparison of tirofiban combined with dalteparin or unfractionated heparin in primary percutaneous coronary intervention of acute ST-segment elevation myocardial infarction patients.
    Li WM; Yang XC; Wang LF; Ge YG; Wang HS; Xu L; Ni ZH; Zhang DP
    Chin Med J (Engl); 2011 Oct; 124(20):3275-80. PubMed ID: 22088520
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Influence of prolonged dalteparin treatment on coagulation, fibrinolysis and inflammation in unstable coronary artery disease.
    Oldgren J; Fellenius C; Boman K; Jansson JH; Nilsson TK; Wallentin L; Siegbahn A
    J Intern Med; 2005 Nov; 258(5):420-7. PubMed ID: 16238677
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Randomised comparison of implantation of heparin-coated stents with balloon angioplasty in selected patients with coronary artery disease (Benestent II).
    Serruys PW; van Hout B; Bonnier H; Legrand V; Garcia E; Macaya C; Sousa E; van der Giessen W; Colombo A; Seabra-Gomes R; Kiemeneij F; Ruygrok P; Ormiston J; Emanuelsson H; Fajadet J; Haude M; Klugmann S; Morel MA
    Lancet; 1998 Aug; 352(9129):673-81. PubMed ID: 9728982
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.